These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15705381)

  • 1. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel.
    Lockhat FB; Emembolu JE; Konje JC
    Fertil Steril; 2005 Feb; 83(2):398-404. PubMed ID: 15705381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
    Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
    Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
    Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
    J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
    Anpalagan A; Condous G
    J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
    Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
    Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of levonorgestrel during long-term use of Norplant].
    Du M; Shao Q; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jun; 34(6):363-5. PubMed ID: 11360617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
    Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial.
    Wong AY; Tang LC; Chin RK
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):273-9. PubMed ID: 20618247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment.
    Engemise SL; Willets JM; Emembolu JO; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):439-42. PubMed ID: 22018831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of levonorgestrel-releasing intrauterine system for adenomyosis].
    He SM; Zhang YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1794-6. PubMed ID: 17259122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
    Sheng J; Lu D; Zhang JP; Cui GF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.